US Stock MarketDetailed Quotes
PHASQ PhaseBio Pharmaceuticals
- 0.000001
- 0.0000000.00%
15min DelayClose Sep 16 16:00 ET
49.86Market Cap0.00P/E (TTM)
0.000000High0.000000Low0Volume0.000000Open0.000001Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)49.86MShares0.00100052wk High0.00P/B34.41Float Cap0.00000152wk Low--Dividend TTM34.41MShs Float16.650000Historical High--Div YieldTTM0.00%Amplitude0.000001Historical Low--Avg Price1Lot Size
PhaseBio Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | (Q2)Jun 30, 2021 | (Q1)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q4)Dec 31, 2020 | (Q3)Sep 30, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 6.12%-10.41M | -124.35%-22.88M | 20.92%-47.42M | -76.24%-19.99M | 61.26%-6.13M | -23.80%-11.09M | 57.19%-10.2M | -51.43%-59.96M | 9.16%-11.35M | -92.08%-15.83M |
| Net income from continuing operations | 41.89%-16.67M | 59.28%-11.14M | -32.98%-131.07M | -41.93%-43.11M | -26.97%-31.92M | -1.91%-28.68M | -83.55%-27.36M | -151.14%-98.57M | -168.07%-30.38M | -120.73%-25.14M |
| Operating gains losses | -250.93%-8.72M | -607.22%-7.23M | 69.36%21.18M | 166.28%10.84M | -26.61%3.14M | 55.80%5.78M | 214.10%1.43M | --12.51M | --4.07M | --4.27M |
| Depreciation and amortization | 3.43%603K | 26.79%601K | 252.95%1.79M | 77.19%606K | 136.36%130K | 922.81%583K | 777.78%474K | 191.95%508K | 584.00%342K | 10.00%55K |
| Other non cash items | -65.85%4.09M | -71.58%3.38M | 5.16%29.04M | -71.57%3.52M | -82.00%1.64M | 125.87%11.99M | 1,407.10%11.89M | 5,423.60%27.62M | 8,385.62%12.39M | 9,033.00%9.13M |
| Change In working capital | 743.47%9.56M | -436.93%-9.09M | 789.07%29.37M | 386.02%8M | 524.11%20.16M | -115.58%-1.49M | 125.23%2.7M | -74.53%-4.26M | 192.62%1.65M | -289.40%-4.75M |
| -Change in receivables | ---- | ---- | --0 | --0 | --18.4M | ---- | ---- | 223.30%1.23M | --0 | --0 |
| -Change in prepaid assets | -31.51%5.4M | -296.89%-1.9M | 189.61%7.51M | 232.32%1.88M | -2,264.43%-3.23M | 216.23%7.89M | 110.05%965K | -328.61%-8.38M | 38.60%-1.42M | -93.69%149K |
| -Change in payables and accrued expense | 784.33%4.37M | -508.20%-7.07M | 340.76%12.69M | 105.03%6.28M | 208.55%5.32M | -110.38%-638K | 221.54%1.73M | 506.32%2.88M | 167.42%3.06M | -989.56%-4.9M |
| -Change in other working capital | ---208K | ---117K | --9.17M | ---158K | ---335K | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 6.12%-10.41M | -124.35%-22.88M | 20.92%-47.42M | -76.24%-19.99M | 61.26%-6.13M | -23.80%-11.09M | 57.19%-10.2M | -51.43%-59.96M | 9.16%-11.35M | -92.08%-15.83M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 76.98%-58K | 63.16%-49K | -89.73%-2.68M | -2,910.91%-1.66M | -258.43%-638K | 51.63%-252K | 79.79%-133K | -47.08%-1.41M | 59.56%-55K | 54.94%-178K |
| Net PPE purchase and sale | 76.98%-58K | 63.16%-49K | -104.19%-2.68M | -2,910.91%-1.66M | -258.43%-638K | 51.63%-252K | 76.16%-133K | -36.67%-1.31M | 59.56%-55K | 54.94%-178K |
| Net intangibles purchase and sale | ---- | ---- | --0 | --0 | ---- | ---- | ---- | ---100K | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 76.98%-58K | 63.16%-49K | -89.73%-2.68M | -2,910.91%-1.66M | -258.43%-638K | 51.63%-252K | 79.79%-133K | -47.08%-1.41M | 59.56%-55K | 54.94%-178K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 64.38%-415K | -100.30%-179K | 312.34%63.77M | 4,097.04%7.09M | -156.97%-1.33M | -138.03%-1.17M | 497.66%59.17M | -71.11%15.47M | -96.54%169K | 3,545.31%2.33M |
| Net issuance payments of debt | 0.00%-1.36M | 0.00%-1.36M | -100.04%-5.46M | -0.07%-1.36M | 0.00%-1.36M | ---1.36M | ---1.36M | -138.13%-2.73M | -127.26%-1.36M | ---1.36M |
| Net common stock issuance | 497.30%735K | -98.04%1.19M | 1,951.46%60.35M | --18K | -100.61%-15K | -139.19%-185K | --60.54M | -93.64%2.94M | --0 | 8,067.74%2.47M |
| Proceeds from stock option exercised by employees | -49.65%213K | --0 | 159.79%730K | 6.69%255K | 108.33%50K | 42,200.00%423K | -88.24%2K | 14.69%281K | 895.83%239K | -74.74%24K |
| Net other financing activities | ---- | ---- | -45.60%8.14M | 532.95%8.18M | --0 | ---- | ---- | 10,424.14%14.97M | --1.29M | --1.2M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 64.38%-415K | -100.30%-179K | 312.34%63.77M | 4,097.04%7.09M | -156.97%-1.33M | -138.03%-1.17M | 497.66%59.17M | -71.11%15.47M | -96.54%169K | 3,545.31%2.33M |
| Net cash flow | ||||||||||
| Beginning cash position | -75.72%18.69M | 48.64%41.8M | -62.01%28.12M | 43.21%56.36M | 21.56%64.46M | 29.48%76.96M | -62.01%28.12M | 21.25%74.03M | -51.87%39.35M | -41.31%53.03M |
| Current changes in cash | 12.98%-10.88M | -147.32%-23.11M | 129.80%13.68M | -29.61%-14.56M | 40.76%-8.1M | -94.93%-12.51M | 434.89%48.84M | -453.81%-45.9M | -44.99%-11.23M | -59.51%-13.67M |
| End cash Position | -87.89%7.8M | -75.72%18.69M | 48.64%41.8M | 48.64%41.8M | 43.21%56.36M | 21.56%64.46M | 29.48%76.96M | -62.01%28.12M | -62.01%28.12M | -51.87%39.35M |
| Free cash flow | 7.70%-10.47M | -121.94%-22.93M | 18.37%-50.1M | -89.91%-21.65M | 57.70%-6.77M | -19.65%-11.34M | 57.80%-10.33M | -51.33%-61.37M | 9.70%-11.4M | -85.35%-16.01M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data